美国 · 平台与数据 · MarketBeat

Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III

来源：MarketBeat · 美国 1 小时前

Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III

推荐阅读

Anthropic's Revenue Surged to $16.3 Billion in the First Half of 2026, Up From $1.1 Billion a Year Ago

Global X Equal Weight Can Insurance Idx ETF declares CAD 0.06 dividend

Saudi Arabia intercepts Houthi missile as Trump threatens new strikes

Hooters closes 35-year-old location after shutting 55 restaurants

SpaceX’s 80,000 Cell Site Push A Win For AST SpaceMobile, Ericsson, Nokia, NextNav, Among Others, Says Roth Capital

The Ensign Group, Inc. Notice of December 7, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III

分享

推荐阅读

Anthropic's Revenue Surged to $16.3 Billion in the First Half of 2026, Up From $1.1 Billion a Year Ago

Global X Equal Weight Can Insurance Idx ETF declares CAD 0.06 dividend

Saudi Arabia intercepts Houthi missile as Trump threatens new strikes

Hooters closes 35-year-old location after shutting 55 restaurants

SpaceX’s 80,000 Cell Site Push A Win For AST SpaceMobile, Ericsson, Nokia, NextNav, Among Others, Says Roth Capital

The Ensign Group, Inc. Notice of December 7, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline